These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35499399)

  • 1. Associations between elevated depressive symptoms and substance use, prescription opioid misuse, overdose history, pain, and general health among community pharmacy patients prescribed opioids.
    Brown JL; Cochran G; Bryan MA; Charron E; Winhusen TJ
    Subst Abus; 2022; 43(1):1110-1115. PubMed ID: 35499399
    [No Abstract]   [Full Text] [Related]  

  • 2. Pain Severity and Interference and Substance Use Among Community Pharmacy Patients Prescribed Opioids: A Secondary Analysis of the PHARMSCREEN Study.
    Charron E; Okifuji A; Bryan MA; Reese S; Brown JL; Ferguson A; Ghitza UE; Winhusen T; Cochran G
    J Pain; 2022 Aug; 23(8):1448-1459. PubMed ID: 35417791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk use by patients prescribed opioids for pain and its role in overdose deaths.
    Gwira Baumblatt JA; Wiedeman C; Dunn JR; Schaffner W; Paulozzi LJ; Jones TF
    JAMA Intern Med; 2014 May; 174(5):796-801. PubMed ID: 24589873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant Cannabis Misuse and Associations with Depression, Pain and Substance Misuse among Patients Prescribed Opioids.
    Bryan MA; Charron E; Adeoye-Olatunde O; Brown J; Ghitza U; Winhusen TJ; Cochran G
    Pharmacy (Basel); 2021 Aug; 9(3):. PubMed ID: 34449714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between prescription and illicit stimulant and opioid use in the United States, 2015-2020.
    Shearer RD; Jones A; Howell BA; Segel JE; Winkelman TNA
    J Subst Abuse Treat; 2022 Dec; 143():108894. PubMed ID: 36206585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription opioid use: Patient characteristics and misuse in community pharmacy.
    Cochran G; Bacci JL; Ylioja T; Hruschak V; Miller S; Seybert AL; Tarter R
    J Am Pharm Assoc (2003); 2016; 56(3):248-256.e6. PubMed ID: 27053277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?
    Edlund MJ; Sullivan M; Steffick D; Harris KM; Wells KB
    Pain Med; 2007; 8(8):647-56. PubMed ID: 18028043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: A cross-sectional study.
    Feingold D; Brill S; Goor-Aryeh I; Delayahu Y; Lev-Ran S
    J Affect Disord; 2018 Aug; 235():293-302. PubMed ID: 29660645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
    Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive multivariate model of biopsychosocial factors associated with opioid misuse and use disorder in a 2017-2018 United States national survey.
    Montiel Ishino FA; McNab PR; Gilreath T; Salmeron B; Williams F
    BMC Public Health; 2020 Nov; 20(1):1740. PubMed ID: 33208132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study.
    Gomes T; Juurlink DN; Antoniou T; Mamdani MM; Paterson JM; van den Brink W
    PLoS Med; 2017 Oct; 14(10):e1002396. PubMed ID: 28972983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risky alcohol use among patients dispensed opioid medications: A clinical community pharmacy study.
    Cochran G; Charron E; Brown JL; Cernasev A; Hohmeier KC; Winhusen TJ
    Drug Alcohol Depend; 2022 May; 234():109406. PubMed ID: 35316690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
    Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
    PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs.
    Bluthenthal RN; Simpson K; Ceasar RC; Zhao J; Wenger L; Kral AH
    Drug Alcohol Depend; 2020 Jun; 211():107932. PubMed ID: 32199668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid use disorder and overdose among youth following an initial opioid prescription.
    Hadland SE; Bagley SM; Gai MJ; Earlywine JJ; Schoenberger SF; Morgan JR; Barocas JA
    Addiction; 2021 Oct; 116(10):2790-2800. PubMed ID: 33739476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan.
    Seal KH; Shi Y; Cohen G; Cohen BE; Maguen S; Krebs EE; Neylan TC
    JAMA; 2012 Mar; 307(9):940-7. PubMed ID: 22396516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A National Retrospective Study of Antidepressants' Effects on Overdose and Self-Harm Among Adults Treated With Opioid Analgesics.
    Sherry TB; Nguyen T; Dick AW; Bradford AC; Simon K; Stein BD
    Psychiatr Serv; 2023 Jan; 74(1):24-30. PubMed ID: 35770423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Overdose in a Retrospective Cohort with Non-Cancer Pain Treated with Opioids, Antidepressants, and/or Sedative-Hypnotics: Interactions with Mental Health Disorders.
    Turner BJ; Liang Y
    J Gen Intern Med; 2015 Aug; 30(8):1081-96. PubMed ID: 25650263
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.